Industry-Sponsored Symposium - Mastering the Management of IBD: Challenging Cases

This activity is supported by an independent educational grant from AbbVie Inc.

The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly, as novel pharmacologic agents continue to advance the treatment of Crohn’s disease and ulcerative colitis. In this live symposium, 3 IBD experts will discuss and differentiate these new and emerging therapies, provide context for their use in clinical practice, and use patient cases to illustrate evolving concepts in risk stratification, treat-to-target approaches, and therapeutic monitoring. The symposium will be presented in a "Test and Teach" format that will pose challenging, case-based questions to the audience to explore the learner’s current knowledge and therapeutic approach, and then “teach” through them in-depth, evidence-based discussion. The program will conclude with an interactive audience Q&A session.

Open to all ACG 2023 attendees, industry-sponsored symposia provide additional educational opportunities. These programs are independent of the ACG 2023 Annual Scientific Meeting and Postgraduate Course programs. ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.

Use the Register button or register at https://www.medscape.org/symposium/ibd-acg-2023.